Inventor · disambiguated record
John Paul Mathias
Also filed as: MATHIAS JOHN · MATHIAS JOHN P · MATHIAS JOHN PAUL
32 granted patents·16 pending applications·508 citations·filing 1998–2023
97Inventor score
Files withPFIZER33CYSTIC FIBROSIS FOUND5CYSTIC FIBROSIS FOUND THERAPEUTICS INC4BARBER CHRISTOPHER G1LEWTHWAITE RUSSELL ANDREW1
Top patents by PatentIndex Score
48 records- 0197US11702424B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2020·Granted Jul 18, 2023·4 cites·8 claims
- 0296US10208053B2Bicyclic heteroaryl derivatives as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2018·Granted Feb 19, 2019·31 cites·19 claims
- 0396US6916927B2Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunctionPFIZER·Filed 2004·Granted Jul 12, 2005·113 cites·2 claims
- 0495US10131670B2Bicyclic heteroaryl derivatives as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·27 cites·8 claims
- 0595US9879022B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2016·Granted Jan 30, 2018·19 cites·22 claims
- 0695US9458168B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2015·Granted Oct 4, 2016·17 cites·44 claims
- 0791US10793579B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2019·Granted Oct 6, 2020·3 cites·8 claims
- 0890US6458951B2Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunctionPFIZER·Filed 2001·Granted Oct 1, 2002·39 cites·2 claims
- 0987US7511057B2Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitorsPFIZER·Filed 2005·Granted Mar 31, 2009·11 cites·22 claims
- 1087US6677335B1Pharmaceutically active compoundsPFIZER·Filed 2000·Granted Jan 13, 2004·28 cites·12 claims
- 1186US10329302B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2018·Granted Jun 25, 2019·3 cites·2 claims
- 1286US6333330B1Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunctionPFIZER·Filed 1999·Granted Dec 25, 2001·39 cites·11 claims
- 1385US12202836B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2023·Granted Jan 21, 2025·0 cites·14 claims
- 1485US10308615B2Heterocyclic compounds as inhibitors of Vanin-1 enzymePFIZER·Filed 2016·Granted Jun 4, 2019·3 cites·8 claims
- 1585US10174000B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2016·Granted Jan 8, 2019·5 cites·10 claims
- 1685US6949573B2Nicotinamide derivatives useful as PDE4 inhibitorsPFIZER·Filed 2003·Granted Sep 27, 2005·19 cites·12 claims
- 1783US10301315B2Pyrrolopyrimidines as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·1 cites·20 claims
- 1881US10494374B2Pyrrolopyrimidines as CFTR potentiatorsCYSTIC FIBROSIS FOUND·Filed 2019·Granted Dec 3, 2019·1 cites·67 claims
- 1979US10377762B2Bicyclic heteroaryl derivatives as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·1 cites·15 claims
- 2079US10316018B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2018·Granted Jun 11, 2019·2 cites·4 claims
- 2177US2023250100A1Pyrrolopyrimidines as CFTR PotentiatorsCYSTIC FIBROSIS FOUND·Filed 2023·Application pending·0 cites
- 2276US7557121B2Tetrahydronaphthyridine derivativesPFIZER·Filed 2005·Granted Jul 7, 2009·3 cites·14 claims
- 2376US6251904B1Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunctionPFIZER·Filed 1999·Granted Jun 26, 2001·35 cites·11 claims
- 2473US7153870B2Nicotinamide derivatives useful as PDE4 inhibitorsPFIZER·Filed 2004·Granted Dec 26, 2006·11 cites·18 claims
- 2573US6670366B1Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunctionPFIZER·Filed 1999·Granted Dec 30, 2003·36 cites·13 claims
- 2672US2020017512A1Pyrrolopyrimidines as cftr potentiatorsCYSTIC FIBROSIS FOUND·Filed 2019·Application pending·0 cites
- 2771US7060717B2Nicotinamide derivatives useful as PDE4 inhibitorsPFIZER·Filed 2004·Granted Jun 13, 2006·4 cites·10 claims
- 2870US6936619B2Quinazolinone compounds useful in therapyPFIZER·Filed 2003·Granted Aug 30, 2005·7 cites·16 claims
- 2969US6407114B1Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunctionPFIZER·Filed 1999·Granted Jun 18, 2002·28 cites·17 claims
- 3069US2021171534A1Pyrrolopyrimidines as CFTR PotentiatorsCYSTIC FIBROSIS FOUND·Filed 2021·Application pending·0 cites
- 3166US7056934B2Nicotinamide derivatives useful as PDE4 inhibitorsPFIZER·Filed 2004·Granted Jun 6, 2006·2 cites·26 claims
- 3265US10766904B2Bicyclic heteroaryl derivatives as CFTR potentiatorsCYSTIC FIBROSIS FOUND·Filed 2019·Granted Sep 8, 2020·0 cites·1 claims
- 3365US7176311B2Process for preparing pharmaceutically active compoundsPFIZER·Filed 2004·Granted Feb 13, 2007·2 cites·5 claims
- 3465US2010035891A1Pharmaceutically Active CompoundsPFIZER·Filed 2009·Application pending·0 cites
- 3559US6723719B1Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunctionPFIZER·Filed 1998·Granted Apr 20, 2004·14 cites·13 claims
- 3658US2005043326A1CompoundsPFIZER·Filed 2004·Application pending·0 cites
- 3758US2006178408A1Nicotinamide derivatives useful as pde4 inhibitorsBARBER CHRISTOPHER G·Filed 2004·Application pending·0 cites
- 3858US2005020611A1CompoundsFiled 2004·Application pending·0 cites
- 3958US2009035313A1CompoundsPFIZER·Filed 2004·Application pending·0 cites
- 4057US2009258861A1Tetrahydronaphthyridine DerivativesLUNN GRAHAM·Filed 2009·Application pending·0 cites
- 4157US2006293347A1Pharmaceutically active compoundsPFIZER·Filed 2006·Application pending·0 cites
- 4257US2019292157A1Novel heterocyclic compounds as inhibitors of vanin-1 enzymePFIZER·Filed 2019·Application pending·0 cites
- 4354US2006014780A1Nicotinamide derivatives useful as PDE4 inhibitorsPFIZER·Filed 2005·Application pending·0 cites
- 4453US8076356B2Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitorsMATHIAS JOHN PAUL·Filed 2009·Granted Dec 13, 2011·0 cites·6 claims
- 4547US2005026952A1Nicotinamide derivatives useful as PDE4 inhibitorsPFIZER·Filed 2004·Application pending·0 cites
- 4646US2009270350A1Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea DerivativesPFIZER·Filed 2007·Application pending·0 cites
- 4744US2009012079A1Triazolopyridine CompoundsLEWTHWAITE RUSSELL ANDREW·Filed 2007·Application pending·0 cites
- 4841US2003220361A1Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseasesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Paul Mathias files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →